Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Back to research

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

20071,382 citationsJournal Articlebronze Open Access

Authors

James J. Vredenburgh · Duke University Hospital

Annick Desjardins · Duke Medical Center

James E. Herndon · Duke University Hospital

Jennifer Marcello · Duke University Hospital

David A. Reardon · Duke University Hospital

Jennifer A. Quinn · Duke University Hospital

Abstract

Bevacizumab and irinotecan is an effective treatment for recurrent glioblastoma multiforme and has moderate toxicity.

Topics & Keywords

Glioma Diagnosis and Treatment Vascular Malformations Diagnosis and Treatment Brain Metastases and Treatment

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Journal of Clinical Oncology

Volume 25, Issue 30, pp. 4722-4729

DOI: 10.1200/jco.2007.12.2440

Field-Weighted Citation Impact: 56.24

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme | Researchclopedia

· Duke Medical Center

Sith Sathornsumetee · Duke University Hospital

Sridharan Gururangan · Duke Medical Center

John H. Sampson · Duke Medical Center

Melissa Wagner · Duke Medical Center

Leighann Bailey · Duke Medical Center

Darell D. Bigner · Duke Medical Center

Allan H. Friedman · Duke University Hospital

Henry S. Friedman · Duke University Hospital